Meeting Materials

Annual Report

Annual Report

View an enhanced version of our Annual Report.

Proxy Statement

Proxy Statement

View an enhanced version of our Proxy Statement.

Request Paper

Request Materials

Request paper copies of the above proxy materials online now, by email or by phone by dialing 866-648-8133.

Voting Image


Your vote is Important!
Please vote your proxy online now or by phone by
dialing 866-892-1702.

Annual Meeting

Annual Meeting

You must register to be eligible to participate in the meeting.

Date: March 2, 2023

Time: 5:00 PM ET

Register By: March 1, 2023 at 5:00 PM ET

About Us

Enanta is a clinical stage biotechnology company dedicated to creating oral drugs for viral infections and liver diseases. Our story began in 1995 when we grew from humble beginnings to the company we are today — one that collaborated with AbbVie to discover two protease inhibitor compounds that were each developed and commercialized as part of an AbbVie combination regimen for chronic hepatitis C virus (MAVYRET® and VIEKIRA PAK®, respectively). Currently, we have a diverse and robust pipeline, including one of the most advanced respiratory virology treatment portfolios in the industry, which we are progressing through clinical development with programs for respiratory syncytial virus, SARS-CoV-2 and human metapneumovirus. We are also advancing a clinical stage program for a combination treatment for chronic hepatitis B virus infection.